{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:51:52Z","timestamp":1792803112827,"version":"4.5.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.clnesp.2024.11.035","type":"journal-article","created":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T02:48:35Z","timestamp":1733885315000},"page":"272-281","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["The relationship between probiotics and prebiotics, kidney dysfunction and mortality \u2013 Results from a longitudinal cohort study and Mendelian randomization"],"prefix":"10.1016","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4251-4603","authenticated-orcid":false,"given":"Ruiyan","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sze Kit","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.S.","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desmond Y.H.","family":"Yap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnesp.2024.11.035_bib1","series-title":"Patient characteristics, and treatment modalities","author":"Incidence","year":"2024"},{"key":"10.1016\/j.clnesp.2024.11.035_bib2","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/ndt\/gfm590","article-title":"CKD stage-to-stage progression in native and transplant kidney disease","volume":"23","author":"Kukla","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.clnesp.2024.11.035_bib3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.kisu.2021.11.003","article-title":"Epidemiology of chronic kidney disease: an update 2022","volume":"12","author":"Kovesdy","year":"2022","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.clnesp.2024.11.035_bib4","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/nrneph.2014.145","article-title":"Economic evaluation of dialysis therapies","volume":"10","author":"Klarenbach","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.clnesp.2024.11.035_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.722206","article-title":"Gut bacterial characteristics of patients with type 2 diabetes mellitus and the application potential","volume":"12","author":"Que","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.clnesp.2024.11.035_bib6","first-page":"490","article-title":"Impact of the synbiotics and urate-lowering therapy on gut microbiota and cytokine profile in patients with chronic gouty arthritis","volume":"13","author":"Kondratiuk","year":"2020","journal-title":"J\u00a0Med Life."},{"key":"10.1016\/j.clnesp.2024.11.035_bib7","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.2147\/COPD.S330976","article-title":"Associations of clinical characteristics and intestinal flora imbalance in stable chronic obstructive pulmonary disease (COPD) patients and the construction of an early warning model","volume":"16","author":"Zeng","year":"2021","journal-title":"Int J Chronic Obstr Pulm Dis"},{"key":"10.1016\/j.clnesp.2024.11.035_bib8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jpsychires.2016.12.007","article-title":"The gut microbiome composition associates with bipolar disorder and illness severity","volume":"87","author":"Evans","year":"2017","journal-title":"J\u00a0Psychiatr Res"},{"key":"10.1016\/j.clnesp.2024.11.035_bib9","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1038\/s41467-018-05184-7","article-title":"Gut microbiota associations with common diseases and prescription medications in a population-based cohort","volume":"9","author":"Jackson","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.clnesp.2024.11.035_bib10","article-title":"Causal effects of specific gut microbiota on chronic kidney diseases and renal function-A two-sample Mendelian randomization study","volume":"15","author":"Li","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.clnesp.2024.11.035_bib11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40168-022-01443-4","article-title":"Perturbed gut microbiome and fecal and serum metabolomes are associated with chronic kidney disease severity","volume":"11","author":"Wang","year":"2023","journal-title":"Microbiome"},{"key":"10.1016\/j.clnesp.2024.11.035_bib12","first-page":"10056","article-title":"Differences in gut microbiota structure in patients with stages 4-5 chronic kidney disease","volume":"13","author":"Wu","year":"2021","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.clnesp.2024.11.035_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.726256","article-title":"Uremic toxin-producing Bacteroides species prevail in the gut microbiota of Taiwanese CKD patients: an analysis using the new Taiwan microbiome baseline","volume":"12","author":"Shivani","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.clnesp.2024.11.035_bib14","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1038\/s41598-017-02989-2","article-title":"Alteration of the gut microbiota in Chinese population with chronic kidney disease","volume":"7","author":"Jiang","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.clnesp.2024.11.035_bib15","doi-asserted-by":"crossref","first-page":"5398","DOI":"10.7150\/thno.41725","article-title":"Integrative metagenomic and metabolomic analyses reveal severity-specific signatures of gut microbiota in chronic kidney disease","volume":"10","author":"Wu","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.clnesp.2024.11.035_bib16","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2217\/fmb.14.140","article-title":"Is there interaction between gut microbial profile and cardiovascular risk in chronic kidney disease patients?","volume":"10","author":"Barros","year":"2015","journal-title":"Future Microbiol"},{"key":"10.1016\/j.clnesp.2024.11.035_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134311","article-title":"Gut-microbiota-metabolite Axis in early renal function decline","volume":"10","author":"Barrios","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.clnesp.2024.11.035_bib18","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1590\/2175-8239-jbn-2018-0214","article-title":"Dietary intake of tyrosine and phenylalanine, and p-cresyl sulfate plasma levels in non-dialyzed patients with chronic kidney disease","volume":"42","author":"Fernandes","year":"2020","journal-title":"J\u00a0Bras Nefrol"},{"key":"10.1016\/j.clnesp.2024.11.035_bib19","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2215\/CJN.03600807","article-title":"Endotoxemia is related to systemic inflammation and atherosclerosis in peritoneal dialysis patients","volume":"3","author":"Szeto","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.clnesp.2024.11.035_bib20","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3747\/pdi.2008.00242","article-title":"Endotoxemia is associated with better clinical outcome in incident Chinese peritoneal dialysis patients: a prospective cohort study","volume":"30","author":"Szeto","year":"2010","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.clnesp.2024.11.035_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/toxins8120358","article-title":"Indoxyl sulfate-review of toxicity and therapeutic strategies","volume":"8","author":"Leong","year":"2016","journal-title":"Toxins"},{"key":"10.1016\/j.clnesp.2024.11.035_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/toxins9020052","article-title":"p-Cresyl Sulfate","volume":"9","author":"Gryp","year":"2017","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.clnesp.2024.11.035_bib23","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1186\/s12967-022-03585-3","article-title":"Probiotics ameliorate IgA nephropathy by improving gut dysbiosis and blunting NLRP3 signaling","volume":"20","author":"Tan","year":"2022","journal-title":"J\u00a0Transl Med"},{"key":"10.1016\/j.clnesp.2024.11.035_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/nu15153363","article-title":"The usefulness of resistant maltodextrin and chitosan oligosaccharide in management of gut leakage and microbiota in chronic kidney disease","volume":"15","author":"Anegkamol","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.clnesp.2024.11.035_bib25","first-page":"77","article-title":"Beneficial effects of Bifidobacteria in a gastroresistant seamless capsule on hyperhomocysteinemia in hemodialysis patients","volume":"15","author":"Taki","year":"2005","journal-title":"J\u00a0Ren Nutr"},{"key":"10.1016\/j.clnesp.2024.11.035_bib26","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1007\/s00125-007-0791-0","article-title":"Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia","volume":"50","author":"Cani","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.clnesp.2024.11.035_bib27","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/ndt\/gfaa335","article-title":"Effect of fructooligosaccharide on endothelial function in CKD patients: a randomized controlled trial","volume":"37","author":"Armani","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.clnesp.2024.11.035_bib28","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/ndt\/gfp414","article-title":"p-Cresyl sulfate serum concentrations in haemodialysis patients are reduced by the prebiotic oligofructose-enriched inulin","volume":"25","author":"Meijers","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.clnesp.2024.11.035_bib29","first-page":"386","article-title":"High-resistant starch, low-protein flour intervention on patients with early type 2 diabetic nephropathy: a randomized trial","volume":"29","author":"Meng","year":"2019","journal-title":"J\u00a0Ren Nutr"},{"key":"10.1016\/j.clnesp.2024.11.035_bib30","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/hdi.12653","article-title":"Effect of high amylose resistant starch (HAM-RS2) supplementation on biomarkers of inflammation and oxidative stress in hemodialysis patients: a randomized clinical trial","volume":"22","author":"Tayebi Khosroshahi","year":"2018","journal-title":"Hemodial Int"},{"key":"10.1016\/j.clnesp.2024.11.035_bib31","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1053\/j.gastro.2021.04.037","article-title":"Nonfood prebiotic, probiotic, and synbiotic use has increased in US adults and children from 1999 to 2018","volume":"161","author":"O'Connor","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clnesp.2024.11.035_bib32","article-title":"Clinical practice guideline for the management of glomerular diseases","volume":"100","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.clnesp.2024.11.035_bib33","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41588-020-00763-1","article-title":"Large-scale association analyses identify host factors influencing human gut microbiome composition","volume":"53","author":"Kurilshikov","year":"2021","journal-title":"Nat Genet"},{"key":"10.1016\/j.clnesp.2024.11.035_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106350","article-title":"Lacticaseibacillus rhamnosus Fmb14 prevents purine induced hyperuricemia and alleviate renal fibrosis through gut-kidney axis","volume":"182","author":"Zhao","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.clnesp.2024.11.035_bib35","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1007\/s00018-019-03155-9","article-title":"Microbiome-metabolomics reveals gut microbiota associated with glycine-conjugated metabolites and polyamine metabolism in chronic kidney disease","volume":"76","author":"Feng","year":"2019","journal-title":"Cell Mol Life Sci : CMLS"},{"key":"10.1016\/j.clnesp.2024.11.035_bib36","first-page":"3207","article-title":"PhenoScanner: a database of human genotype-phenotype associations","volume":"32","author":"Staley","year":"2016","journal-title":"Bioinformatics (Oxford, England)"},{"key":"10.1016\/j.clnesp.2024.11.035_bib37","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.34408","article-title":"The MR-Base platform supports systematic causal inference across the human phenome","volume":"7","author":"Hemani","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.clnesp.2024.11.035_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/nu14081637","article-title":"Probiotics-supplemented low-protein diet for microbiota modulation in patients with advanced chronic kidney disease (ProLowCKD): results from a placebo-controlled randomized trial","volume":"14","author":"De Mauri","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.clnesp.2024.11.035_bib39","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/ki.2012.440","article-title":"The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease","volume":"83","author":"Anders","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.clnesp.2024.11.035_bib40","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10157-016-1255-y","article-title":"The role of the gastrointestinal tract and microbiota on uremic toxins and chronic kidney disease development","volume":"21","author":"Briskey","year":"2017","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.clnesp.2024.11.035_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/toxins13040252","article-title":"The impact of CKD on uremic toxins and gut microbiota","volume":"13","author":"Rysz","year":"2021","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.clnesp.2024.11.035_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MNH.0b013e32835b36c1","article-title":"Renal microvascular dysfunction, hypertension and CKD progression","volume":"22","author":"Bidani","year":"2013","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.clnesp.2024.11.035_bib43","first-page":"28","article-title":"Probiotic supplementation in chronic kidney disease: a double-blind, randomized, placebo-controlled trial","volume":"28","author":"Borges","year":"2018","journal-title":"J\u00a0Ren Nutr"},{"key":"10.1016\/j.clnesp.2024.11.035_bib44","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1590\/2175-8239-jbn-3931","article-title":"Probiotics in the treatment of chronic kidney disease: a systematic review","volume":"40","author":"Fagundes","year":"2018","journal-title":"J\u00a0Bras Nefrol"},{"key":"10.1016\/j.clnesp.2024.11.035_bib45","first-page":"36","article-title":"Kidney function improvement by soy milk containing Lactobacillus plantarum A7 in type 2 diabetic patients with nephropathy: a double-blinded randomized controlled trial","volume":"11","author":"Abbasi","year":"2017","journal-title":"Iran J Kidney Dis"},{"key":"10.1016\/j.clnesp.2024.11.035_bib46","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1186\/s12967-023-04570-0","article-title":"Washed microbiota transplantation improves renal function in patients with renal dysfunction: a retrospective cohort study","volume":"21","author":"Zhong","year":"2023","journal-title":"J\u00a0Transl Med"},{"key":"10.1016\/j.clnesp.2024.11.035_bib47","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/ismej.2011.109","article-title":"Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers","volume":"6","author":"Wang","year":"2012","journal-title":"ISME J"},{"key":"10.1016\/j.clnesp.2024.11.035_bib48","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13073-016-0290-3","article-title":"Microbiota-based model improves the sensitivity of fecal immunochemical test for detecting colonic lesions","volume":"8","author":"Baxter","year":"2016","journal-title":"Genome Med"},{"key":"10.1016\/j.clnesp.2024.11.035_bib49","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12944-021-01440-w","article-title":"Compositional alterations of gut microbiota in nonalcoholic fatty liver disease patients: a systematic review and Meta-analysis","volume":"20","author":"Li","year":"2021","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.clnesp.2024.11.035_bib50","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/nm.3914","article-title":"The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment","volume":"21","author":"Zhang","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.clnesp.2024.11.035_bib51","doi-asserted-by":"crossref","first-page":"6717","DOI":"10.1007\/s11033-020-05727-6","article-title":"Oral administration of Flavonifractor plautii attenuates inflammatory responses in obese adipose tissue","volume":"47","author":"Mikami","year":"2020","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.clnesp.2024.11.035_bib52","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3389\/fimmu.2020.00379","article-title":"Oral administration of flavonifractor plautii strongly suppresses Th2 immune responses in mice","volume":"11","author":"Ogita","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.clnesp.2024.11.035_bib53","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1161\/CIRCRESAHA.122.321975","article-title":"Flavonifractor plautii protects against elevated arterial stiffness","volume":"132","author":"Luo","year":"2023","journal-title":"Circ Res"},{"key":"10.1016\/j.clnesp.2024.11.035_bib54","article-title":"Oral administration of flavonifractor plautii, a bacteria increased with green tea consumption, promotes recovery from acute colitis in mice via suppression of IL-17","volume":"7","author":"Mikami","year":"2020","journal-title":"Front Nutr"},{"key":"10.1016\/j.clnesp.2024.11.035_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.idcr.2018.e00461","article-title":"Flavonifractor (Eubacterium) plautii bloodstream infection following acute cholecystitis","volume":"14","author":"Berger","year":"2018","journal-title":"IDCases"},{"key":"10.1016\/j.clnesp.2024.11.035_bib56","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1399-0012.2008.00805.x","article-title":"Eubacterium plautii infection in a kidney transplant recipient: a noteworthy case of pleural effusion and fever","volume":"22","author":"Orlando","year":"2008","journal-title":"Clin Transplant"},{"key":"10.1016\/j.clnesp.2024.11.035_bib57","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12866-017-0977-7","article-title":"Lactobacillus-derived extracellular vesicles enhance host immune responses against vancomycin-resistant enterococci","volume":"17","author":"Li","year":"2017","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.clnesp.2024.11.035_bib58","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s40168-016-0195-9","article-title":"Intestinal microbiota in pediatric patients with end stage renal disease: a Midwest Pediatric Nephrology Consortium study","volume":"4","author":"Crespo-Salgado","year":"2016","journal-title":"Microbiome"},{"key":"10.1016\/j.clnesp.2024.11.035_bib59","article-title":"Exploring the relevance between gut microbiota-metabolites profile and chronic kidney disease with distinct pathogenic factor","volume":"11","author":"Chen","year":"2023","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.clnesp.2024.11.035_bib60","article-title":"Alterations of gut microbes and their correlation with clinical features in middle and end-stages chronic kidney disease","volume":"13","author":"Chen","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.clnesp.2024.11.035_bib61","first-page":"611","article-title":"Immune enhancement conferred by oral delivery of Lactobacillus rhamnosus HN001 in different milk-based substrates","volume":"68","author":"Gill","year":"2001","journal-title":"J\u00a0Dairy Res"},{"key":"10.1016\/j.clnesp.2024.11.035_bib62","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.resmic.2010.03.001","article-title":"Importance of lactobacilli in food and feed biotechnology","volume":"161","author":"Giraffa","year":"2010","journal-title":"Res Microbiol"},{"key":"10.1016\/j.clnesp.2024.11.035_bib63","first-page":"38","article-title":"Probiotics and disease: a comprehensive summary-Part 8, gastrointestinal and genitourinary disorders","volume":"17","author":"Finley","year":"2018","journal-title":"Integr Med (Encinitas)."},{"key":"10.1016\/j.clnesp.2024.11.035_bib64","series-title":"Take probiotics with caution as some efficacy unproven 25 samples not clearly labelled introduce regulation to protect consumer health","year":"2024"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457724015444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457724015444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T10:47:19Z","timestamp":1737370039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405457724015444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":64,"alternative-id":["S2405457724015444"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2024.11.035","relation":{},"ISSN":["2405-4577"],"issn-type":[{"value":"2405-4577","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The relationship between probiotics and prebiotics, kidney dysfunction and mortality \u2013 Results from a longitudinal cohort study and Mendelian randomization","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2024.11.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}